James Lu, MD, PhD

Chief Executive Officer & Co-founder

Sarah Bobulsky

Chief Financial Officer

Craig Newman

SVP of Health Systems & Strategic Partnerships

Daniel Lee

SVP of Life Sciences & Growth

David Becker, PhD

VP of Quality & Research and Development

Jim Chou

VP of Engineering

Marc Laurent

VP of Partnerships & Operations

Will Lee, PhD

VP of Science

Elissa Levin

VP of Clinical & Policy

Leslie Liang

VP, Legal

Kirsten Mouritsen

Director of Product Management

Wendy Chung, M.D., Ph.D.

Wendy Chung, M.D., Ph.D. is a clinical and molecular geneticist and the Kennedy Family Professor of Pediatrics and Medicine and Director of Clinical Genetics. Dr. Chung directs research programs in human genetics of obesity, breast cancer, pulmonary hypertension, autism, and more. She is a national leader in the ethical, legal, and social implications of genomics; leads the Precision Medicine Resource in the Irving Institute At Columbia University; and has served on the Institute of Medicine Committee on Genetic Testing.

Nita Farahany, J.D., Ph.D.

Nita Farahany, J.D., Ph.D. is Professor of Law and Philosophy, Director of Duke Science & Society at Duke University, and a member of the Presidential Commission for the Study of Bioethics. Her research focuses on how developments in behavioral genetics and neuroscience inform societal norms about privacy and individual liberty.

Judy Garber, M.D., MPH

Judy Garber, M.D., MPH is Professor of Medicine at Harvard Medical School and Director, Center for Cancer Genetics and Prevention at Dana Farber Cancer Institute. Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer.